NCT05131685 · Ann & Robert H Lurie Children's Hospital of Chicago
Distal Radius Interventions for Fracture Treatment
(DRIFT)
What this study is about
This protocol describes a conducted at multiple hospitals, forward-looking randomly assigned superiority trial with a patient preference group of participants comparing functional outcomes between children treated with sedated reduction versus no formal reduction.
View original scientific description
This protocol describes a multicenter, prospective randomized superiority trial with a patient preference cohort comparing functional outcomes between children treated with sedated reduction versus no formal reduction.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Provision of signed and dated informed consent form by parent or legal guardian
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 4-10 years
- Diagnosis of 100% dorsally displaced radius metaphyseal fracture with any or no ulna involvement
- Fracture is less than 5cm from the distal radial growth plate
- Willing to adhere to the immobilization regimen
- Fracture is acute (occurred less than 10 days prior to consent and assignment of treatment arm AND with ability to be taken to operating room (OR) or reduced in the emergency department (ED)
Exclusion criteria
- Physeal involvement of fracture
- Presence of open fracture, pathologic fracture, neuromuscular disease, or metabolic disease
- Fractures other than the ulna near the same level in the ipsilateral arm
- Fracture cannot be treated with acute reduction due to being older than 10 days
- Patient and parents are unable to adhere to procedures or complete follow-up due to insufficient comprehension of consent form or surveys or developmental delay
Where
- Phoenix, Arizona
- Los Angeles, California
- Wilmington, Delaware
- Miami, Florida
- Indianapolis, Indiana
- Baltimore, Maryland
- Boston, Massachusetts
- Minneapolis, Minnesota
- Saint Paul, Minnesota
- Jackson, Mississippi
- New Brunswick, New Jersey
- Albuquerque, New Mexico
And 10 more locations — see the full list below.
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 1, 2026 · Source of record for eligibility and locations